Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Rosa

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Gastroenterologie Clinique Et Biologique|April 20, 2004
[Chronic abdominal pain due to bowel ischemia in a patient with Leiden factor V mutation]Ariane Chryssostalis, Hervé Hagège, Isabelle Rosa-Hezode, et al.
Hepatology (Baltimore, Md.)|February 9, 2017
Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United StatesBenjamin Cadier, Julie Bulsei, Pierre Nahon, et al.
Clinics and Research in Hepatology and Gastroenterology|February 7, 2012
Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patientsJean-David Zeitoun, Isabelle Rosa-Hézode, Ariane Chryssostalis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2013
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approachSylvie Deuffic-Burban, Philippe Mathurin, Isabelle Rosa, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approachAbbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitisChristophe Duvoux, Catherine Radier, Françoise Roudot-Thoraval, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Cancer|March 29, 2018
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide studyCharlotte E Costentin, Abbas Mourad, Pierre Lahmek, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Gastroenterologie Clinique Et Biologique|April 20, 2004
[Chronic abdominal pain due to bowel ischemia in a patient with Leiden factor V mutation]Ariane Chryssostalis, Hervé Hagège, Isabelle Rosa-Hezode, et al.
Hepatology (Baltimore, Md.)|February 9, 2017
Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United StatesBenjamin Cadier, Julie Bulsei, Pierre Nahon, et al.
Clinics and Research in Hepatology and Gastroenterology|February 7, 2012
Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patientsJean-David Zeitoun, Isabelle Rosa-Hézode, Ariane Chryssostalis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2013
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approachSylvie Deuffic-Burban, Philippe Mathurin, Isabelle Rosa, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approachAbbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitisChristophe Duvoux, Catherine Radier, Françoise Roudot-Thoraval, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Cancer|March 29, 2018
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide studyCharlotte E Costentin, Abbas Mourad, Pierre Lahmek, et al.
Pageof 5